publication date: Dec. 20, 2010

In this issue: 

NCI advisors approve recompetition of $62 million phase II contracts program.

Also AIDS Malignancy Consortium grants to be consolidated on recompetition to one central group chairman’s office.

Advisors approve set-aside for alternative medicine “best case series.”

HHS bans tobacco from its campuses, opens national quitline, 1-800-QUITNOW.

Two founding cancer center directors step down: Harold Moses at Vanderbilt-Ingram and Charles Coltman at CTRC.

Funding opportunities listed.

November issue of Business & Regulatory Report, an additional 8 pages, included in this issue.

Download (PDF 848KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.